Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Common variable immunodeficiency: association between memory B cells and lung diseases.

Drahomíra Detková1, Javier de Gracia, Susana Lopes-da-Silva

  • 1Immunology Unit, University Hospital Vall d'Hebron, Barcelona, Spain.

Chest
|April 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

American journal of respiratory and critical care medicine·2026
Same author

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

The Lancet. Respiratory medicine·2026
Same author

Bronchiectasis in Italy: an analysis of the EMBARC registry.

ERJ open research·2026
Same author

Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis.

Nature communications·2025
Same author

Correction: Fernández Blanco et al. A Photonic Immunosensor Detection Method for Viable and Non-Viable <i>E. coli</i> in Water Samples. <i>Microorganisms</i> 2024, <i>12</i>, 1328.

Microorganisms·2025
Same author

Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study.

The Lancet. Respiratory medicine·2025

Low memory B cell (MB) counts in common variable immunodeficiency (CVID) patients correlate with severe respiratory and intestinal issues. MB levels may help predict CVID patient outcomes.

Area of Science:

  • Immunology
  • Clinical Medicine
  • Pulmonology

Background:

  • Common variable immunodeficiency (CVID) frequently causes malabsorption syndrome.
  • The reasons for structural damage in some CVID patients remain unclear.
  • Defects in memory B cells (MBs), crucial for antibody production, are linked to CVID complications.

Purpose of the Study:

  • To investigate the association between memory B cell (MB) defects and clinical outcomes in CVID patients.
  • To determine if MB quantification can predict respiratory and intestinal involvement severity.

Main Methods:

  • Forty-one CVID patients were classified into three groups based on peripheral MB counts: MB2 (normal), MB1 (low switched), and MB0 (absent/low).
  • Clinical outcomes of respiratory and intestinal involvement were compared across the MB groups.

Related Experiment Videos

Main Results:

  • Patients in the MB0 group showed significantly higher rates of chronic lung disease (50%) and malabsorption syndrome/diarrhea (50%) compared to MB1 and MB2 groups (p < 0.05).
  • No significant differences were observed in age at onset, diagnostic delay, follow-up duration, or prediagnostic IgG levels among groups.

Conclusions:

  • Memory B cell (MB) count alterations are linked to severe respiratory and intestinal manifestations in CVID.
  • MB count serves as a potential biomarker for guiding prognosis and management strategies in CVID patients.